Antiproliferative compounds and bispecific antibody against bcma and cd3 for combined use
US-2024366593-A1 · Nov 7, 2024 · US
This page is not indexed by search engines while we improve data quality.
Pierce Daniel W patents
Pierce Daniel W is listed as an inventor on 26 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Pierce Daniel W |
| Total patents | 26 |
| First publication | Mar 8, 2018 |
| Latest publication | Nov 7, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Combination therapy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
US-12090147-B2 · Sep 17, 2024 · US
Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
US-12061183-B2 · Aug 13, 2024 · US
Antiproliferative compounds and bispecific antibody against BCMA and CD3 for combined use
US-12053466-B2 · Aug 6, 2024 · US
Antiproliferative compounds and methods of use thereof
US-12029738-B2 · Jul 9, 2024 · US
Antiproliferative compounds and methods of use thereof
US-2024207255-A1 · Jun 27, 2024 · US
Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile
US-2023341375-A1 · Oct 26, 2023 · US
Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
US-2023243806-A1 · Aug 3, 2023 · US
Antiproliferative compounds and bispecific antibody against bcma and cd3 for combined use
US-2023181575-A1 · Jun 15, 2023 · US
Combination therapy for acute myeloid leukemia
US-2023149379-A1 · May 18, 2023 · US
Recent patents
Latest publications not already listed above.
Antiproliferative compounds and bispecific antibody against BCMA and CD3 for combined use
US-11439637-B2 · Sep 13, 2022 · US
Antiproliferative compounds and methods of use thereof
US-2022280505-A1 · Sep 8, 2022 · US
Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
US-11320416-B1 · May 3, 2022 · US
Antiproliferative compounds and methods of use thereof
US-11185543-B2 · Nov 30, 2021 · US
Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile
US-2021181184-A1 · Jun 17, 2021 · US
Combination therapy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
US-2021128545-A1 · May 6, 2021 · US
Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
US-10900951-B1 · Jan 26, 2021 · US
Antiproliferative compounds and methods of use thereof
US-2020253964-A1 · Aug 13, 2020 · US
Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
US-10705070-B1 · Jul 7, 2020 · US
Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
US-10527604-B1 · Jan 7, 2020 · US
Antiproliferative compounds and bispecific antibody against bcma and cd3 for combined use
US-2019381035-A1 · Dec 19, 2019 · US
Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile
US-2019361005-A1 · Nov 28, 2019 · US
Antiproliferative compounds and methods of use thereof
US-2019282567-A1 · Sep 19, 2019 · US
Antiproliferative compounds and methods of use thereof
US-10357489-B2 · Jul 23, 2019 · US
Antiproliferative compounds and methods of use thereof
US-2019008852-A1 · Jan 10, 2019 · US
Method for treating cancer based on level of glucocorticoid receptor
US-2018064679-A1 · Mar 8, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Celgene Corp | 19 |
| Abraxis Bioscience Llc | 7 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K45/06 | 20 |
| A61P35/02 | 19 |
| A61P35/00 | 18 |
| A61K31/496 | 16 |
| A61K2300/00 | 16 |